Innovate UK grant awarded for development of quantum computing in cancer treatment
A Medicines Discovery Catapult (MDC) scientist has landed the award for ‘Best Poster’ at the ELRIG Drug Discovery Conference 2021.
Dr. Laura Ajram, Psychiatry Consortium Programme Manager at Medicines Discovery Catapult (MDC) has landed the prestigious ELRIG Early Career Impact Award 2021.
Medicines Discovery Catapult (MDC) today announces the reappointment of Prof. Chris Molloy as CEO from January 2022.
Medicines Discovery Catapult (MDC) today announces the reappointment of experienced scientist and investor Dr Robin Brown, as Chairman.
Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting an innovative funding model aimed at opening new funding opportunities for early-stage medicines discovery.
The facility, which was closed in 2020, includes the multi-million pound cyclotron, one of only a handful in the UK.
The BioIndustry Association (BIA), the Wellcome Sanger Institute and Medicines Discovery Catapult (MDC) have today launched Genomics Nation.
The Catapult Network is ready to play a key role in implementing the strategy and supporting industrial sectors to innovate.
The CEOs of all nine Catapults came together at a special event held in the High Value Manufacturing Catapult’s MTC in Coventry to sign the shared Inclusivity in Innovation Charter.
See how we can help support you with your next drug discovery project.
Speak to us